Zura Bio Limited Class A Share Price

Zura Bio Limited Class A Share Price

NASDAQ: ZURA | Small Cap
$4.05
+$0.22 (5.74%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Zura Bio Limited Class A Stock Performance

Open
$3.85
Prev. Close
$3.83
Circuit Range
N/A
Day Range
$3.65 - $4.06
Year Range
$3.28 - $7.40
Volume
2,13,267
Average Traded
$3.86

Zura Bio Limited Class A Share Price Today

As of 31 October 2026, Zura Bio Limited Class A's share price is $4.05. The stock opened at $3.85, compared to its previous close of $3.83. During today's trading session, Zura Bio Limited Class A's share price traded between $3.65 and $4.06, with an average price of $3.86. Over the past 52 weeks, the stock has recorded a high of $7.40 and a low of $3.28. In terms of performance, Zura Bio Limited Class A's share price has declined by 20.33% over the last six months and is up 5.60% on a year-on-year basis.

Zura Bio Limited Class A Share Price Chart

Line chart of the Zura Bio Limited Class A price trend over the selected period. The price rose overall, ranging from 3.65 to 4.06, ending at 4.06.
$3.65$4.06
L
Show Current Price
H

Zura Bio Limited Class A Stock Fundamentals & Key Indicators

Market Cap
$381.82M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.27
Revenue (TTM)
$0.00
Return On Equity (TTM)
-68.80%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
43.70%

Zura Bio Limited Class A Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$45.88-$24.22-$26.30-$25.83
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A47.21%-8.59%1.79%

Zura Bio Limited Class A Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$69.24-$45.39-$99.35
Net Profit MarginN/AN/AN/A
Income ChangeN/A34.45%-118.88%

About Zura Bio Limited Class A

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Zura Bio Limited Class A Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$4.13
$4.05
-2.55%
Sep 2026
$5.52
$4.16
-28.89%
Aug 2026
$5.43
$5.85
+7.83%
Jul 2026
$5.87
$5.42
-7.97%
Jun 2026
$4.25
$5.89
+37.09%
May 2026
$5.13
$4.30
-15.52%
Apr 2026
$5.97
$5.09
-14.17%
Mar 2026
$6.45
$5.93
-10.15%
Feb 2026
$5.67
$6.60
+15.59%
Jan 2026
$5.32
$5.71
+9.18%
Dec 2025
$3.67
$5.23
+35.14%
Nov 2025
$3.88
$3.87
+0.78%

ZURA Share Price FAQs